{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:03Z","timestamp":1786997943645,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor and Welfare of Japan","award":["H26-Shinko Gyousei-Shitei-002"],"award-info":[{"award-number":["H26-Shinko Gyousei-Shitei-002"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.07.111","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T20:14:50Z","timestamp":1440792890000},"page":"6106-6111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8"],"prefix":"10.1016","volume":"33","author":[{"given":"Akiko","family":"Eto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-4464","authenticated-orcid":false,"given":"Tomoya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3079-7754","authenticated-orcid":false,"given":"Hiroyuki","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kurane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.111_bib0250","series-title":"Vaccinia viruses as vectors for vaccine antigens","first-page":"87","article-title":"Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain","author":"Hashizume","year":"1985"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0255","first-page":"269","article-title":"Report of the National Smallpox Vaccination Research Committee: study of side effects, complications and their treatments","volume":"3","author":"Yamaguchi","year":"1975","journal-title":"Rinsho to Uirusu"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0260","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1473-3099(05)70242-5","article-title":"Smallpox vaccine and its stockpile in 2005","volume":"5","author":"Arita","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.20965\/jdr.2009.p0329","article-title":"Research on preparedness for bioterrorism-associated events in Japan: smallpox vaccine preparedness","volume":"4","author":"Saito","year":"2009","journal-title":"J Disaster Res"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0275","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0280","unstructured":"Nishiyama Y, personal communication (under submission)."},{"key":"10.1016\/j.vaccine.2015.07.111_bib0285","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0290","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection","volume":"79","author":"Morikawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0295","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"Saijo","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0300","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0305","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00040-09","article-title":"Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model","volume":"16","author":"Meseda","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0310","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"Gordon","year":"2011","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0315","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00199-14","article-title":"Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice","volume":"21","author":"Yokote","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0320","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0325","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2217\/fmb.10.98","article-title":"Third-generation smallpox vaccines: challenges in the absence of clinical smallpox","volume":"5","author":"Meseda","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0335","series-title":"Vaccines","first-page":"718","article-title":"Smallpox and vaccinia","author":"Kennedy","year":"2013"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0340","unstructured":"21 CFR Section 601.90: Approval of biological products when human efficacy studies are not ethical or feasible."},{"key":"10.1016\/j.vaccine.2015.07.111_bib0345","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0350","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0355","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0360","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/518793","article-title":"Antibody responses to vaccinia membrane proteins after smallpox vaccination","volume":"196","author":"Lawrence","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0365","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations","volume":"12","author":"Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0370","series-title":"Highly attenuated smallpox vaccine LC16m8 protects mice against lethal orthopoxvirus challenge over the long term","author":"Yokote","year":"2008"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0375","series-title":"Long-term protective efficacy and antibody response induced by a single dose of attenuated smallpox vaccine LC16m8","author":"Yokote","year":"2009"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0380","unstructured":"Yokote Report on research grants from the Japanese Health Sciences Foundation (KHC1204), 2011."},{"key":"10.1016\/j.vaccine.2015.07.111_bib0385","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0390","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"P\u00fctz","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0395","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"Engelstad","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0400","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/JVI.66.12.7217-7224.1992","article-title":"Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope","volume":"66","author":"Isaacs","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0405","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0410","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/JVI.74.8.3771-3780.2000","article-title":"Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein","volume":"74","author":"Ward","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0415","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0042-6822(91)90480-Y","article-title":"Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins","volume":"181","author":"Takahashi-Nishimaki","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0425","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1099\/vir.0.034207-0","article-title":"Serological responses in humans to the smallpox vaccine LC16m8","volume":"92","author":"Johnson","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0430","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0435","doi-asserted-by":"crossref","first-page":"e67984","DOI":"10.1371\/journal.pone.0067984","article-title":"Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model","volume":"8","author":"Meseda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0440","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0445","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0450","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0455","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/prca.200780113","article-title":"Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome","volume":"2","author":"Schmid","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0460","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.vaccine.2008.12.035","article-title":"The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays","volume":"27","author":"Duke-Cohan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0465","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1128\/JVI.02089-12","article-title":"Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations","volume":"87","author":"Townsend","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0470","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0475","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/JVI.02127-10","article-title":"Capturing the natural diversity of the human antibody response against vaccinia virus","volume":"85","author":"Lantto","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.111_bib0480","unstructured":"WHO. Weekly epidemiological record. 2014:89 1\u201320."},{"key":"10.1016\/j.vaccine.2015.07.111_bib0485","unstructured":"WHO Summary report on first, second and third generation smallpox vaccines, \u3008http:\/\/www.who.int\/immunization\/sage\/meetings\/2013\/november\/2_Smallpox_vaccine_review_updated_11_10_13.pdf\u3009; 2013 [last accessed 05.05.15]."},{"key":"10.1016\/j.vaccine.2015.07.111_bib0490","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T14:53:20Z","timestamp":1599490400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15011792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":49,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15011792"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.111","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}